cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.3886/e155923
title: Healthcare access brokerage by school employees for Immigrant Mexican and Indigenous Guatemalan farmworking families in a Connecticut elementary school

description: It is known that Florida school employees facilitate or broker healthcare access for migrant and farmworking families, but it is not known how states without a Migrant Education Program might also broker healthcare access. The present study examines the role of school employees in brokering healthcare access to immigrant Mexican and Indigenous Guatemalan farmworking families in Connecticut. Informed by prior work, interviews (n=12) with parents and elementary school employees showed that 1) a vast array of non-Migrant Advocate school employees, mostly women, directly brokered physical and psychosocial healthcare access, and 2) barriers to brokerage included language inaccessibility, school employee gaps in knowledge of MSF healthcare needs, and transportation issues. Importantly, the school’s location near MSF homes is an important contributor to the success of the school’s brokerage efforts. Findings offer insight into how a school health broker model might be implemented, and advance understandings of MSF health and healthcare access.
DOI: 10.3886/e155923v1
title: Healthcare access brokerage by school employees for Immigrant Mexican and Indigenous Guatemalan farmworking families in a Connecticut elementary school

description: It is known that Florida school employees facilitate or broker healthcare access for migrant and farmworking families, but it is not known how states without a Migrant Education Program might also broker healthcare access. The present study examines the role of school employees in brokering healthcare access to immigrant Mexican and Indigenous Guatemalan farmworking families in Connecticut. Informed by prior work, interviews (n=12) with parents and elementary school employees showed that 1) a vast array of non-Migrant Advocate school employees, mostly women, directly brokered physical and psychosocial healthcare access, and 2) barriers to brokerage included language inaccessibility, school employee gaps in knowledge of MSF healthcare needs, and transportation issues. Importantly, the school’s location near MSF homes is an important contributor to the success of the school’s brokerage efforts. Findings offer insight into how a school health broker model might be implemented, and advance understandings of MSF health and healthcare access.
DOI: 10.21223/ushwlu/eben1d
title: 02_Data_Dictionary.tab

description: :unav
DOI: 10.21223/ushwlu/gbiomk
title: 01_SanRamon_Junin.tab

description: :unav
DOI: 10.21223/ushwlu
title: Dataset for: Meteorological data at San Ramon CIP experimental station from 2004 to 2011

description: In the present dataset, hourly meteorological data at San Ramon CIP Experimental Station from July 2004 to November 2011 is available. The meteorological variables are the following variables: Air temperature (°C), relative humidity (%), vapor pressure deficit (kPa), wind speed (m s^-1), wind direction (cardinals direction of compass rose), solar radiation (W m^-2), atmospheric pressure (hPa), rain (mm) and potential evapotranspiration (mm). Data from an automatic weather station Vantage Pro Plus.
DOI: 10.26180/17118959
title: Thermal assay data associated with Camus, M. F., et al. (2017). "Experimental Support That Natural Selection Has Shaped the Latitudinal Distribution of Mitochondrial Haplotypes in Australian Drosophila melanogaster." Molecular Biology and Evolution 34(10): 2600-2612.

description: Data associated with heat and cold stress assays from Camus, M. F., et al. (2017). "Experimental Support That Natural Selection Has Shaped the Latitudinal Distribution of Mitochondrial Haplotypes in Australian Drosophila melanogaster." Molecular Biology and Evolution 34(10): 2600-2612.<br>
DOI: 10.26180/17118959.v1
title: Thermal assay data associated with Camus, M. F., et al. (2017). "Experimental Support That Natural Selection Has Shaped the Latitudinal Distribution of Mitochondrial Haplotypes in Australian Drosophila melanogaster." Molecular Biology and Evolution 34(10): 2600-2612.

description: Data associated with heat and cold stress assays from Camus, M. F., et al. (2017). "Experimental Support That Natural Selection Has Shaped the Latitudinal Distribution of Mitochondrial Haplotypes in Australian Drosophila melanogaster." Molecular Biology and Evolution 34(10): 2600-2612.<br>
DOI: 10.6084/m9.figshare.17118968
title: Spreadsheet - Review - Organizational Climate Measures

description: Spreadsheet - Review - Organizational Climate Measures
DOI: 10.21223/bjoijl/4klfdf
title: 01_LaVictoria_Junin.tab

description: :unav
DOI: 10.21223/bjoijl/wdnuu2
title: 02_Data_Dictionary.tab

description: :unav
DOI: 10.21223/bjoijl
title: Dataset for: Meteorological data at La Victoria CIP experimental station from 2004 to 2012

description: In the present dataset, hourly meteorological data at La Victoria CIP Experimental Station from July 2004 to May 2012 is available. The meteorological variables are the following variables: Air temperature (°C), relative humidity (%), vapor pressure deficit (kPa), wind speed (m s^-1), wind direction (cardinals direction of compass rose), solar radiation (W m^-2), atmospheric pressure (hPa), rain (mm) and potential evapotranspiration (mm). Data from an automatic weather station Vantage Pro Plus.
DOI: 10.17632/r63n3b9rm8.1
title: The Pb isotope evolution of Bulk Silicate Earth: constraints from its accretion and early differentiation history

description: raw data sheet with model calculations
DOI: 10.6084/m9.figshare.17118827
title: Swanson et al., 2017 -- aeolianBedformSurfaceModel --Simulation #1 temporal subset as netCDF

description: <b>Summary:</b>Included netCDF file is a subset of simulation #1 results from Swanson et al., 2017 "A Surface Model for Aeolian Dune Topography" saved as a well-formatted netCDF file. <br><b>Details:</b>* default simualtion parameters were used.* only the first 500 timesteps of the simulation were recorded into the netcdf file.* the ordering for "easting" and "northing" coordinates in the netCDF file is opposite from the paper---the data are the same, but the source region is along the second axis; thus the display is different from the original paper.* simulation used the model code included as a supplement to the paper found here:https://static-content.springer.com/esm/art:10.1007/s11004-016-9654-x/MediaObjects/11004_2016_9654_MOESM5_ESM.txt<br>* simulation was executed on 12/02/2021 with Matlab R2021a on Ubuntu 20.04<br><b>Reference:</b>Swanson, T., Mohrig, D., Kocurek, G. et al. A Surface Model for Aeolian Dune Topography. Math Geosci 49, 635–655 (2017). https://doi.org/10.1007/s11004-016-9654-x<br>
DOI: 10.6084/m9.figshare.16764199
title: Thaumarchaeota MAGs from Riverton, WY

description: Thaumarchaeota draft genomes assembled from a 2m deep soil/sediment core in Riverton, Wyoming.
DOI: 10.5517/ccdc.csd.cc1mjzpt
title: CCDC 1505877: Experimental Crystal Structure Determination

description: Related Article: Samvel N. Sirakanyan, Domenico Spinelli, Victor A. Kartsev, Athina Geronikaki, Elmira K. Hakobyan, Armen G. Ayvazyan, Rafael A. Tamazyan, Anush A. Hovakimyan|2021|Curr.Org.Chem.|25|1704|doi:10.2174/1570179418666210621092546
DOI: 10.5517/ccdc.csd.cc1nrt6f
title: CCDC 1542225: Experimental Crystal Structure Determination

description: Related Article: Samvel N. Sirakanyan, Domenico Spinelli, Victor A. Kartsev, Athina Geronikaki, Elmira K. Hakobyan, Armen G. Ayvazyan, Rafael A. Tamazyan, Anush A. Hovakimyan|2021|Curr.Org.Chem.|25|1704|doi:10.2174/1570179418666210621092546
DOI: 10.5517/ccdc.csd.cc27wvxx
title: CCDC 2082360: Experimental Crystal Structure Determination

description: Related Article: Qi-Lin Guo, Bao-Liang Han, Cun-Fa Sun, Zhi Wang, Yunwen Tao, Jin-Qing Lin, Geng-Geng Luo, Chen-Ho Tung, Di Sun|2021|Nanoscale|13|19642|doi:10.1039/D1NR05567D
DOI: 10.5517/ccdc.csd.cc28gnw9
title: CCDC 2099471: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gnxb
title: CCDC 2099472: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gnyc
title: CCDC 2099473: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gnzd
title: CCDC 2099474: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gp0g
title: CCDC 2099475: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gp1h
title: CCDC 2099476: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gp2j
title: CCDC 2099477: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.5517/ccdc.csd.cc28gp3k
title: CCDC 2099478: Experimental Crystal Structure Determination

description: Related Article: Mark D. Straub, Erik T. Ouellette, Michael A. Boreen, R. David Britt, Khetpakorn Chakarawet, Iskander Douair, Colin A. Gould, Laurent Maron, Iker Del Rosal, David Villarreal, Stefan G. Minasian, John Arnold|2021|J.Am.Chem.Soc.|143|19748|doi:10.1021/jacs.1c07854
DOI: 10.21223/ff5czt/sfomzu
title: 05_Potato French Fries Processing Results Chota 2019-2020.tab

description: :unav
DOI: 10.21223/ff5czt/g5pd4s
title: 04_Potato French Fries Processing Results Huamachuco 2019-2020.tab

description: :unav
DOI: 10.21223/ff5czt/qczarw
title: 01_Potato French Fries Processing Results Quilcas 2019-2020.tab

description: :unav
DOI: 10.21223/ff5czt/d2s1vo
title: 02_Potato French Fries Processing Results Majes 2019-2020.tab

description: :unav
DOI: 10.21223/ff5czt/vgtud0
title: 03_Potato French Fries Processing Results Huanuco 2019-2020.tab

description: :unav
DOI: 10.6084/m9.figshare.16879618
title: analysis scripts

description: analysis scripts for preprocessing MEG data and decoding
DOI: 10.6084/m9.figshare.17072390.v2
title: MOSAICA datasets

description: This package includes all the experimental datasets that were used for the figures in the paper '<i>Spatial transcriptomics using combinatorial fluorescence spectral and lifetime encoding, imaging and analysis</i>'.Each folder is associated to a figure (3 through 6) and each experiment is accompanied by a csv file with the extracted data.The raw data can be analyzed using our image processing pipeline for MATLAB, available in FigShare:MOSAICA software (figshare.com)<br>
DOI: 10.21223/lviarz/j85ad0
title: Farmer DATASET_cleaned.tab

description: :unav
DOI: 10.21223/lviarz/3wmpok
title: Traders DATA_cleaned.tab

description: :unav
DOI: 10.21223/lviarz/xjxguy
title: Farmer DATASET_cleaned. excel.xlsx

description: :unav
DOI: 10.21223/lviarz/aep2x3
title: Traders DATA_cleaned. excel.tab

description: :unav
DOI: 10.21223/lviarz/q6trrc
title: Consumer COMBINED DATA_cleaned.excel.xlsx

description: :unav
DOI: 10.21223/lviarz/jikrms
title: Consumer COMBINED DATA_cleaned.tab

description: :unav
DOI: 10.25934/00006766
title: Pregabalin Add-On Titration Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Partial Seizures

description: To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures
DOI: 10.25934/00007218
title: A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study To Evaluate The Clinical Efficacy And Safety Of Tolterodine ER 4 mg In Men Who Have Frequency and Urgency, With Or Without Urinary Urge Incontinence, With Or Without Bladder Outlet Obstruction

description: The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
DOI: 10.25934/00007219
title: A Multi-Center, Double-Phase, Randomized, Double-Blind, Placebo Controlled (12-Week Double-Blind Followed by 12-Week Open-Label) Study Evaluating the Effect of Tolterodine ER on Urgency Urinary Incontinence (UUI), Urgency, Frequency, Sexual Quality of Life and Sexual Function in Women With Overactive Bladder

description: The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
DOI: 10.25934/00005669
title: Safety and Pharmacokinetics of Valganciclovir Syrup Formulation in Pediatric Solid Organ Transplant Recipients

description: This study will assess the safety and pharmacokinetics of Valcyte syrup in pediatric solid organ transplant recipients. The anticipated time on study treatment is 3-12 months and the target sample size is less than 100 individuals.
DOI: 10.25934/00005721
title: An Open-label, Multicentre, Nonrandomized, Dose-escalating Phase I/II Study, With a Randomized Phase II Part, to Investigate the Safety and Tolerability of RO5072759 Given as Monotherapy in Patients With CD20+ Malignant Disease.

description: The primary objective for the phase I part of the study is to investigate the safety and tolerability of escalating intravenous (IV) doses of obinutuzumab given as monotherapy in participants with CD20+ (tumor-infiltrating lymphocytic) Malignant Disease, including B-cell chronic lymphocytic leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL). The primary objective for the phase II part of the study is to investigate the efficacy and safety of one dose of obinutuzumab in participants with relapsed/refractory CLL and NHL that is, in turn, either indolent (iNHL) or aggressive (aNHL). It is an open label dose escalating study in phase I and open label in phase II, but the two doses in iNHL & aNHL are randomized (to high or low dose of the same open label treatment). CLL was not randomized as only one dose level was used. Participants with a response who might gain additional benefit from being treated again in the opinion of the investigator may be enrolled in a Retreatment Period.
DOI: 10.25934/00005664
title: A Randomized, Open-label Study of the Effect of PEGASYS Combined With Ribavirin on Sustained Virologic Response in Patients With Chronic Hepatitis C Who Did Not Respond to Previous Pegintron/Ribavirin Combination Therapy

description: This 4 arm study is designed for patients with CHC who have not responded to peginterferon alfa-2b (12KD)/ribavirin combination therapy. In these patients, the effects of lengthening the duration of treatment, as well as including an initial 12-week period of high-dose PEGASYS (360 micrograms sc), are compared with the standard combination therapy of PEGASYS (180 micrograms sc) and ribavirin (1000-1200mg po). The anticipated time on study treatment is 1-2 years and the target sample size is 500+ individuals.
DOI: 10.25934/00005694
title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Efficacy and Safety of up to 100 Days of Valganciclovir Versus up to 200 Days of Valganciclovir for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Kidney Allograft Recipients

description: This study will determine the relative efficacy and safety of up to 100 days Valcyte prophylaxis relative to up to 200 days Valcyte prophylaxis when given for the prevention of CMV disease in high-risk (D+/R-) kidney allograft recipients. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.
DOI: 10.25934/00005700
title: A Randomized, Multicenter, Double Blinded Study Comparing the Safety and Efficacy of Pegasys® 180 ug Plus Copegus® 1000 or 1200 mg to the Currently Approved Combination of Pegasys® 180 ug Plus Copegus® 800 mg in Interferon-naïve Patients With Chronic Hepatitis C Genotype 1 Virus Infection and HIV-1

description: This 2-arm study will compare the efficacy and safety of treatment with Pegasys (180 µg weekly) plus Copegus (800 mg daily) and Pegasys (180 µg weekly) plus Copegus (1000-1200 mg daily) in interferon-naive patients with CHC genotype 1 co-infected with HIV-1. Treatment will be administered for 48 weeks, and this will be followed by 24 treatment-free weeks. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.
DOI: 10.25934/00005653
title: Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B

description: The purpose of this study is to determine the safety and efficacy of Pegasys + placebo + lamivudine versus lamivudine alone in patients with lamivudine versus lamivudine alone in patients with hepatitis B antigen CHB.
DOI: 10.25934/00006000
title: An Open-Label Randomized Phase III Study Comparing Xeloda (Capecitabine) With IV Bolus 5-Fluorouracil in Combination With Low-Dose Leucovorin as Adjuvant Chemotherapy in Patients Who Underwent Surgery for Dukes C Colon Cancer

description: This 2 arm study will compare the safety and efficacy of oral Xeloda, or 5-fluorouracil in combination with leucovorin, in patients who have undergone surgery for colon cancer. Patients will be randomized to receive either Xeloda 1250mg/m2 po bid on days 1-14 every 21 days, or leucovorin 20mg/m2 iv + 5-fluorouracil 425mg/m2 iv daily from day 1 to day 5 every 28 days. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.
DOI: 10.25934/00006491
title: An Open-Label, Multicenter Study to Assess the Safety of RO5185426 (Vemurafenib) in Patients With Metastatic Melanoma

description: This multi-center study evaluates the safety and efficacy of vemurafenib in participants with BRAF V600 mutation-positive, surgically incurable, and unresectable Stage IIIC or IV (American Joint Committee on Cancer [AJCC]) metastatic melanoma.
DOI: 10.25934/00005657
title: A 2x2 Factorial Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) ("XELOX") With/Without Intravenous Bevacizumab (Q3W) Versus Bolus and Continuous Infusion Fluorouracil/Intravenous Leucovorin With Intravenous Oxaliplatin (Q2W) ("FOLFOX-4") With/Without Intravenous Bevacizumab (Q2W) as First-line Treatment for Patients With Metastatic Colorectal Cancer

description: This 4 arm study assessed the efficacy and safety of oral capecitabine (Xeloda) or intravenous (iv) fluorouracil/leucovorin, in combination with iv oxaliplatin (Eloxatin) with or without iv bevacizumab (Avastin), as a first-line treatment in patients with metastatic colorectal cancer. Patients were randomized to receive 1) XELOX (Xeloda 1000 mg/m^2 orally [po] twice a day [bid] on Days 1-15 + oxaliplatin in 3 week cycles), 2) FOLFOX-4 (oxaliplatin + leucovorin + fluorouracil [5-FU] in 2 week cycles), 3) XELOX + bevacizumab (7.5 mg iv on Day 1 in 3 week cycles), or 4) FOLFOX-4 + bevacizumab (5 mg iv on Day 1 in 2 week cycles).
DOI: 10.21223/g3jk72/va509i
title: PTYield102019_ACACHAYO_exp9.tab

description: :unav
DOI: 10.21223/g3jk72/x0pkt6
title: PTPVS102019_CAÑAYPATA.tab

description: :unav
DOI: 10.21223/g3jk72/evauz8
title: PTPVS102019_SANTA CRUZ DE PACCHO.tab

description: :unav
DOI: 10.21223/g3jk72/rztfjh
title: PTPVS102019_CCASAPATA.tab

description: :unav
DOI: 10.21223/g3jk72/wabq9a
title: PTPVS102019_CIELO_AZUL.tab

description: :unav
DOI: 10.21223/g3jk72/0sd7m3
title: PTPVS102019_CANLALAI.tab

description: :unav
DOI: 10.21223/g3jk72/hglvoz
title: PTYield102019_PATAPATA_exp8.tab

description: :unav
DOI: 10.21223/g3jk72/abdzwo
title: PTYield102019_CASACANCHA_exp7.tab

description: :unav
DOI: 10.21223/g3jk72/swhsss
title: PTYield102019_HUAQUIA_exp6.tab

description: :unav
DOI: 10.21223/g3jk72/30pm10
title: PTYield102019_CHACRAMPA_exp10.tab

description: :unav
DOI: 10.26186/146060
title: Barest Earth Sentinel 2 Map Index

description: The Barest Earth Sentinel-2 Map Index dataset depicts the 1 to 250 000 maps sheet tile frames that have been used to generate individual tile downloads of the Barest Earth Sentinel-2 product. This web service is designed to be used in conjunction with the Barest Earth Sentinel-2 web service to provide users with direct links for imagery download.
DOI: 10.6084/m9.figshare.17119031
title: Figure.docx

description: <b>教师心理健康与应对方式关系的元分析</b><b></b><b>——中国大陆教师样本</b><b></b>
DOI: 10.5517/ccdc.csd.cc28kcks
title: CCDC 2102065: Experimental Crystal Structure Determination

description: Related Article: Ruyan Zhao, Randy P. Sabatini, Tong Zhu, Sasa Wang, Amin Morteza Najjarian, Andrew Johnston, Alan J. Lough, Sjoerd Hoogland, Edward H. Sargent, Dwight S. Seferos|2021|J.Am.Chem.Soc.|143|19901|doi:10.1021/jacs.1c09515
DOI: 10.5517/ccdc.csd.cc28kclt
title: CCDC 2102066: Experimental Crystal Structure Determination

description: Related Article: Ruyan Zhao, Randy P. Sabatini, Tong Zhu, Sasa Wang, Amin Morteza Najjarian, Andrew Johnston, Alan J. Lough, Sjoerd Hoogland, Edward H. Sargent, Dwight S. Seferos|2021|J.Am.Chem.Soc.|143|19901|doi:10.1021/jacs.1c09515
DOI: 10.5517/ccdc.csd.cc28ks7w
title: CCDC 2102458: Experimental Crystal Structure Determination

description: Related Article: Qi-Lin Guo, Bao-Liang Han, Cun-Fa Sun, Zhi Wang, Yunwen Tao, Jin-Qing Lin, Geng-Geng Luo, Chen-Ho Tung, Di Sun|2021|Nanoscale|13|19642|doi:10.1039/D1NR05567D
DOI: 10.5517/ccdc.csd.cc28ks9y
title: CCDC 2102460: Experimental Crystal Structure Determination

description: Related Article: Qi-Lin Guo, Bao-Liang Han, Cun-Fa Sun, Zhi Wang, Yunwen Tao, Jin-Qing Lin, Geng-Geng Luo, Chen-Ho Tung, Di Sun|2021|Nanoscale|13|19642|doi:10.1039/D1NR05567D
DOI: 10.6084/m9.figshare.17030138.v3
title: Transaction records

description: Financial transaction records from 09/2017 to 11/2017
DOI: 10.25912/rdf_1638495738287
title: Lipid Isomer Compartmentalisation
DOI: 10.6084/m9.figshare.16834825
title: Metadata on the oxidative stress related RNA-seq samples in the dataset used for the meta-analysis (OS dataset)

description: Information on oxidative stress related RNA-seq samples used for meta-analysis is organized as the dataset called OS dataset. It includes information on pairs of oxidative stress and normal state samples.